MI
KWON KIM
Profesor asociado de Ciencias de la Salud
CARLOS JAVIER
ANGUITA VELASCO
Profesor asociado de Ciencias de la Salud
Publications by the researcher in collaboration with CARLOS JAVIER ANGUITA VELASCO (33)
2024
-
Advantages of high cell concentration prior to cryopreservation of initial leukapheresis in CAR-T cell therapy
Blood transfusion = Trasfusione del sangue, Vol. 22, Núm. 3, pp. 239-245
-
Digital PCR Improves Sensitivity and Quantification in Monitoring CAR-T Cells in B Cell Lymphoma Patients
Transplantation and Cellular Therapy, Vol. 30, Núm. 3, pp. 306.e1-306.e12
-
Identification of predictive models including polymorphisms in cytokines genes and clinical variables associated with post-transplant complications after identical HLA-allogeneic stem cell transplantation
Frontiers in Immunology, Vol. 15
2023
-
Poor graft function after haploidentical stem cell transplantation with post-transplant cyclophosphamide
Annals of Hematology, Vol. 102, Núm. 6, pp. 1561-1567
-
Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy
Frontiers in immunology, Vol. 14, pp. 1165759
2022
-
Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation
Frontiers in immunology, Vol. 13, pp. 1002959
-
FLT3-ITD Expression as a Potential Biomarker for the Assessment of Treatment Response in Patients with Acute Myeloid Leukemia
Cancers, Vol. 14, Núm. 16
2021
-
Clinical Utility of the Detection of the Loss of the Mismatched HLA in Relapsed Hematological Patients After Haploidentical Stem Cell Transplantation With High-Dose Cyclophosphamide
Frontiers in Immunology, Vol. 12
-
Elafin as a Predictive Biomarker of Acute Skin Graft-Versus-Host Disease After Haploidentical Stem Cell Transplantation Using Post-Transplant High-Dose Cyclophosphamide
Frontiers in Immunology, Vol. 12
-
Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant
Frontiers in Immunology, Vol. 12
-
Next generation cytogenetics in myeloid hematological neoplasms: Detection of cnvs and translocations
Cancers, Vol. 13, Núm. 12
-
Post-transplant cyclophosphamide for GVHD prophylaxis compared to ATG-based prophylaxis in unrelated donor transplantation
Annals of Hematology, Vol. 100, Núm. 2, pp. 541-553
2020
-
Autologous stem cell transplantation for lymphoma in HIV+ patients: higher rate of infections compared with non-HIV lymphoma
Bone Marrow Transplantation, Vol. 55, Núm. 9, pp. 1716-1725
-
Cytokine release syndrome after allogeneic stem cell transplantation with posttransplant cyclophosphamide
Hematological Oncology, Vol. 38, Núm. 4, pp. 597-603
-
Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide
Biology of Blood and Marrow Transplantation, Vol. 26, Núm. 11, pp. 2089-2097
2019
-
Allogeneic stem-cell transplantation in HIV-1-infected patients with high-risk hematological disorders
AIDS, Vol. 33, Núm. 9, pp. 1441-1447
-
Factors predicting peripheral blood progenitor cell mobilization in healthy donors in the era of related alternative donors: Experience from a single center
Journal of Clinical Apheresis, Vol. 34, Núm. 4, pp. 373-380
-
Mononuclear cell collection for extracorporeal photopheresis by using the “off-line” system: A comparative study between COBE Spectra and Spectra Optia devices
Journal of Clinical Apheresis, Vol. 34, Núm. 4, pp. 359-366
-
Next-generation sequencing improves diagnosis, prognosis and clinical management of myeloid neoplasms
Cancers, Vol. 11, Núm. 9
-
Posttransplant cyclophosphamide vs cyclosporin A and methotrexate as GVHD prophylaxis in matched sibling transplantation
Blood Advances, Vol. 3, Núm. 21, pp. 3351-3359